All
Pausing Endocrine Therapy for Pregnancy May Not Impact Breast Cancer Recurrence Risk
May 30th 2023Women with hormone receptor-positive breast cancer who temporarily interrupted endocrine therapy for pregnancy had a similar recurrence rate to those from a control group, but one expert said that stopping therapy for a short time is still an important decision.
The Oncology Nurse Who Radiates Positivity
May 29th 2023Imagine you just received a diagnosis of leukemia; you have no idea what the next steps will be or what your future holds, but you’re greeted with a smile from a nurse who reassures you that “You are in the right place, and we will help you through everything.”
Foreign-Born Patients With HCC May Have Improved Survival Versus U.S.-Born Patients
May 25th 2023Patients born outside of the U.S. may have improved liver cancer survival rates compared with U.S.-born patients, although more research is needed to determine what may be driving this effect, research showed.